Author(s):
Sakshi Guru, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti
Email(s):
nitinpadole27@gmail.com
DOI:
10.52711/2231-5659.2025.00015 
Address:
Sakshi Guru*, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti
Kamla Nehru College of Pharmacy Butibori, Nagpur, Maharashtra (India)-441108.
*Corresponding Author
Published In:
Volume - 15,
Issue - 1,
Year - 2025
ABSTRACT:
This comprehensive review investigates the market landscape of Antibiotics medications, undertaking a detailed comparative analysis of branded and generic options. In the face of rising global prevalence of antibiotics, the study aims to provide a holistic perspective on the efficacy, safety, and market dynamics shaping the use of branded and generic drugs in the management of these chronic conditions. Utilizing data derived from market trends, sales analytics, and consumer preferences, the review scrutinizes the market behaviors and forces influencing the adoption of branded and generic antibiotic drugs. Factors such as cost-effectiveness, patient adherence, and healthcare provider preferences are explored to shed light on the complexities associated with medication selection in the context of chronic disease management. Through an in-depth examination of industry strategies, regulatory frameworks, and the role of healthcare policies, the review aims to uncover the interplay between market dynamics and clinical considerations. It seeks to inform healthcare professionals, policymakers, and industry stakeholders about the evolving landscape of choices in antibiotics therapies, fostering a nuanced understanding that can guide optimal decision-making in patient care and resource allocation.
Cite this article:
Sakshi Guru, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti. A Review: A Comparative Study of Branded and Generic Antibiotics. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(1):99-4. doi: 10.52711/2231-5659.2025.00015
Cite(Electronic):
Sakshi Guru, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti. A Review: A Comparative Study of Branded and Generic Antibiotics. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(1):99-4. doi: 10.52711/2231-5659.2025.00015 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-1-15
REFERENCES:
1. Prasad AM, Chakraborty G, Yadav SS, Bhatia S. Addressing the social determinants of health through health system strengthening and inter-sectoral convergence: the case of the Indian National Rural Health Mission. Global Health Action. 2013 Dec 1; 6(1): 20135.BJERKEDAL, T.: Over Weight and Hypertension. Acta Med Scand. 1957; 159:13.
2. Katz L, Baltz RH. Natural product discovery: past, present, and future. Journal of Industrial Microbiology and Biotechnology. 2016 Mar 1; 43(2-3): 155-76.
3. Prescott JF. The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology. Veterinary Microbiology. 2014 Jul 16; 171(3-4): 273-8.
4. Rodgers A, Lawes C, MacMahon S. Reducing the global burden of blood pressure-related cardiovascular disease. Journal of hypertension. Supplement: Official Journal of the International Society of Hypertension. 2000 May 1; 18(1): S3-6.
5. Thomas, Molly. Rational drug use and essential drug concept. A Textbook of Clinical Pharmacy Practice. 2004; 1: 72-3.
6. Shankar PR, Subish P, Mishra P, Lalit M. 35. Ambiguous pricing of Nepalesemedicines. Journal of Institute of Medicine. 2007 Mar 13; 28(3).
7. Rataboli PV, Dang A. Antimicrobial price variation: Conundrum of medical profession!. Journal of Postgraduate Medicine. 2007 Jan 1; 53(1): 72.
8. Remesh A, Salim S, Gayathri AM, Nair U, Retnavally KG. Antibiotics prescribing pattern in the in-patient departments of a tertiary care hospital. Arch Pharm Pract. 2013 Apr 1; 4(2): 71.
9. Pichholiya M, Basu A, Yadav AK, Kothari N, Tahashildar J. An observational comparative study of cost between branded medicines and generic medicines. Int J Basic Clin Pharmacol. 2015 Mar; 4(2): 269-72.
10. Björkman J, Andersson DI. The cost of antibiotic resistance from a bacterial perspective. Drug Resistance Updates. 2000 Aug 1; 3(4): 237-45.
11. Padole NN. Synthesis of Silver Nanoparticles for Antibacterial Activity against Staphylococcus Aureus and Escherichia Coli. Asian Journal of Pharmaceutical Research and Development. 2022 Apr 15; 10(2): 29-36.
12. Vyavahare S, Padole N, Avari J. A Review: Silver Nanoparticles in Wound Healing. Eur. J. Pharm. Med. Res. 2021; 8: 212-8.
13. Padole N, Avari J. Synthesis of Silver Nanoparticles for Antibacterial Activity against Staphylococcus Aureus and Escherichia Coli. Asian Journal of Pharmaceutical Research and Development. 2021; 9(5): 67-73.
14. Nitin P, Jasmine A. Synthesis and characterization of cefixime loaded silver nanoparticles for antibacterial activity against Staphylococcus aureus.
15. Shrikant R. Dod, Amar G. Mundhe, Pankaj R. Dhapke, Nitin N. Padole, Nilakshi G. Mahakalkar. Pre-formulation Characteristics of Ticagrelor: A Comprehensive Exploration. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(3): 227-0. doi: 10.52711/2231-5659.2024.00037
16. Padole Nitin, Avari Jasmine, Synthesis and characterization of cefixime loaded silver nanoparticles for antibacterial activity against Staphylococcus aureus. Journal of Medical Pharmaceutical and Allied Sciences. 2022; 11(15): 5246 – 5253. doi: 10.55522/jmpas.V11I5.2194.